Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 1/2006

01-02-2006 | Progress in Hematology

Rituximab (anti-cd20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment

Authors: Emilia Parodi, Bruno Nobili, Silverio Perrotta, Sofia Maria Rosaria Matarese, Giovanna Russo, Maria Licciardello, Marco Zecca, Franco Locatelli, Simone Cesaro, Gianni Bisogno, Paola Giordano, Domenico De Mattia, Ugo Ramenghi

Published in: International Journal of Hematology | Issue 1/2006

Login to get access
Metadata
Title
Rituximab (anti-cd20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment
Authors
Emilia Parodi
Bruno Nobili
Silverio Perrotta
Sofia Maria Rosaria Matarese
Giovanna Russo
Maria Licciardello
Marco Zecca
Franco Locatelli
Simone Cesaro
Gianni Bisogno
Paola Giordano
Domenico De Mattia
Ugo Ramenghi
Publication date
01-02-2006
Publisher
Springer-Verlag
Published in
International Journal of Hematology / Issue 1/2006
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.E0518

Other articles of this Issue 1/2006

International Journal of Hematology 1/2006 Go to the issue

Progress in Hematology

Replication of human immunodeficiency virus type 1 from entry to exit

Case Report

Marked hepatomegaly due to aa type amyloidosis in a case with castleman’s disease

Case Report

Varicella-zoster virus encephalitis in a patient undergoing unrelated cord blood transplantation for myelodysplastic syndrome—overt leukemia

Progress in Hematology

Acquired immunodeficiency syndrome—related malignancies in the era of highly active antiretroviral therapy

Progress in Hematology

Delineation of immunoregulatory properties of adult T-cell leukemia cells

Letter to the Editor

Carotid sinus syncope in a patient with relapsed cervical lymphoma
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits